Abiopharma

Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia

Runway Growth Finance Corp. Announces Second Quarter 2026 Dividend of $0.33 per Share

InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares

Manhattan Associates Recognized as a Leader in the Gartner® Magic Quadrant™ for WMS

Capri Holdings Limited Announces Reporting Date For Fourth Quarter and Fiscal 2026 Financial Results

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

UL Solutions Launches Certification Services for Hydrogen Fueling Components, Helping to Build Safety into the Adoption of Hydrogen Power

Norfolk Southern to present at Bank of America 2026 Industrials, Transportation & Airlines Key Leaders Conference

Intuit Unveils QuickBooks Workforce, Radically Transforming Human Capital Management for Small and Mid-Market Businesses

Blue Gold Announces Important Procedural Success in Arbitration Against the Republic of Ghana